EPISODE · Jun 17, 2021 · 43 MIN
Matthew Davis — Bringing Genetic Insights to Everyone
from Gradient Dissent: Conversations on AI
Matthew explains how combining machine learning and computational biology can provide mainstream medicine with better diagnostics and insights.---Matthew Davis is Head of AI at Invitae, the largest and fastest growing genetic testing company in the world. His research includes bioinformatics, computational biology, NLP, reinforcement learning, and information retrieval. Matthew was previously at IBM Research AI, where he led a research team focused on improving AI systems.Connect with Matthew:📍 Personal website: https://www.linkedin.com/in/matthew-davis-51233386/📍 Twitter: https://twitter.com/deadsmiths---⏳ Timestamps:0:00 Sneak peek, intro1:02 What is Invitae?2:58 Why genetic testing can help everyone7:51 How Invitae uses ML techniques14:02 Modeling molecules and deciding which genes to look at22:22 NLP applications in bioinformatics27:10 Team structure at Invitae36:50 Why reasoning is an underrated topic in ML40:25 Why having a clear buy-in is important🌟 Transcript: http://wandb.me/gd-matthew-davis 🌟Links:📍 Invitae: https://www.invitae.com/en📍 Careers at Invitae: https://www.invitae.com/en/careers/---Get our podcast on these platforms:👉 Apple Podcasts: http://wandb.me/apple-podcasts👉 Spotify: http://wandb.me/spotify👉 Google Podcasts: http://wandb.me/google-podcasts👉 YouTube: http://wandb.me/youtube👉 Soundcloud: http://wandb.me/soundcloudJoin our community of ML practitioners where we host AMAs, share interesting projects and meet other people working in Deep Learning:http://wandb.me/slackCheck out Fully Connected, which features curated machine learning reports by researchers exploring deep learning techniques, Kagglers showcasing winning models, industry leaders sharing best practices, and more:https://wandb.ai/fully-connected
NOW PLAYING
Matthew Davis — Bringing Genetic Insights to Everyone
No transcript for this episode yet
Similar Episodes
Apr 22, 2025 ·32m
Feb 27, 2025 ·0m
Sep 20, 2024 ·57m
Aug 7, 2024 ·16m